{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T08:20:29Z","timestamp":1775809229085,"version":"3.50.1"},"reference-count":11,"publisher":"Elsevier BV","issue":"47","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.vaccine.2020.09.073","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T08:45:52Z","timestamp":1602578752000},"page":"7455-7457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Blistering autoimmune skin reaction following SHINGRIX vaccination in an ulcerative colitis patient: Case report and literature review"],"prefix":"10.1016","volume":"38","author":[{"given":"Harrison","family":"Bell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uni","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.vaccine.2020.09.073_b0005","first-page":"540","article-title":"Vaccinating patients with inflammatory bowel disease","volume":"12","author":"Reich","year":"2016","journal-title":"Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.vaccine.2020.09.073_b0010","doi-asserted-by":"crossref","first-page":"103","DOI":"10.15585\/mmwr.mm6703a5","article-title":"Recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines","volume":"67","author":"Dooling","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2020.09.073_b0015","unstructured":"Public Information from the CDC. https:\/\/www.cdc.gov\/vaccines\/vpd\/shingles\/public\/SHINGRIX\/index.html#side-effects [accessed January 16, 2020]."},{"key":"10.1016\/j.vaccine.2020.09.073_b0020","unstructured":"Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases. In: Hamborsky J, Kroger A, Wolfe S (Eds.) 13th ed. Washington D.C.: Public Health Foundation; 2015 [accessed January 16, 2020]."},{"key":"10.1016\/j.vaccine.2020.09.073_b0025","series-title":"Bullous pemphigoid","author":"Baigrie","year":"2018"},{"issue":"5","key":"10.1016\/j.vaccine.2020.09.073_b0030","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2230.2012.04383.x","article-title":"Association between the subepidermal autoimmune blistering diseases linear IgA disease and the pemphigoid group and inflammatory bowel disease: two case reports and literature review","volume":"37","author":"Shipman","year":"2012","journal-title":"Clin Exp Dermatol"},{"issue":"12","key":"10.1016\/j.vaccine.2020.09.073_b0035","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1080\/00365521.2017.1380839","article-title":"Ulcerative colitis associated with pemphigus: a population-based large-scale study","volume":"52","author":"Kridin","year":"2017","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"10.1016\/j.vaccine.2020.09.073_b0040","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/bjd.13872","article-title":"Immunobullous disease and ulcerative colitis: a case series of six patients","volume":"173","author":"Sotiriou","year":"2015","journal-title":"Br J Dermatol"},{"issue":"11","key":"10.1016\/j.vaccine.2020.09.073_b0045","first-page":"1328","article-title":"Bullous pemphigoid after herpes zoster vaccine administration: association or coincidence","volume":"10","author":"Chac\u00f3n","year":"2011","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"10.1016\/j.vaccine.2020.09.073_b0050","first-page":"e4920","article-title":"Uveitis sarcoidosis presumably initiated after administration of SHINGRIX vaccine","volume":"11","author":"Heydari-Kamjani","year":"2019","journal-title":"Cureus"},{"issue":"60","key":"10.1016\/j.vaccine.2020.09.073_b0055","first-page":"1","article-title":"Three case reports of post immunization and post viral bullous pemphigoid: looking for the right trigger","volume":"17","author":"Baroero","year":"2017","journal-title":"BMC Pediatr"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2031255X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2031255X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:49:43Z","timestamp":1759402183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2031255X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":11,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0264410X2031255X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.09.073","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blistering autoimmune skin reaction following SHINGRIX vaccination in an ulcerative colitis patient: Case report and literature review","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.09.073","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}